BioTelemetry, Inc.
BEAT
BEAT was delisted on the 8th of February, 2021.
192 hedge funds and large institutions have $856M invested in BioTelemetry, Inc. in 2017 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 79 increasing their positions, 63 reducing their positions, and 48 closing their positions.
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
25% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 63
3% less capital invested
Capital invested by funds: $884M → $856M (-$28.5M)
9% less funds holding
Funds holding: 211 → 192 (-19)
20% less call options, than puts
Call options by funds: $3.58M | Put options by funds: $4.49M
40% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 48
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$21.7M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$15.1M |
| 3 |
SCM
Sterling Capital Management
Charlotte,
North Carolina
|
+$12.5M |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$11.9M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$11.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
Castleark Management
Chicago,
Illinois
|
-$14.4M |
| 2 |
Renaissance Technologies
New York
|
-$11.4M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$11.3M |
| 4 |
Millennium Management
New York
|
-$10.1M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$5.91M |
BEAT Hedge Fund Activity: Q4 2017 in Review
192 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q4 2017, worth a combined $856M — down 3.2% from $884M a quarter earlier.
Sellers outnumbered buyers: 48 funds closed out of BEAT and 29 opened new positions — a net loss of 19 holders — while 63 trimmed existing stakes and 79 added.
The largest buyer was Macquarie Group, adding an estimated $21.7M. The largest seller was Castleark Management, exiting entirely with an estimated $14.4M sold.
- 192 institutional investors held BioTelemetry, Inc. (BEAT) as of Q4 2017, down from 211 in Q3 2017.
- Funds reported $856M of BioTelemetry, Inc. stock for Q4 2017, down 3.2% quarter-over-quarter.
- 29 funds opened new BioTelemetry, Inc. positions in Q4 2017 and 48 closed out, a net change of -19 holders.
- The largest BioTelemetry, Inc. buyer in Q4 2017 was Macquarie Group, an estimated $21.7M added.
- The largest BioTelemetry, Inc. seller in Q4 2017 was Castleark Management, an estimated $14.4M sold.
Based on aggregated 13F filings for Q4 2017.